Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus (T2DM)”

870 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 870 results

Not applicableNot Yet RecruitingNCT07414277
What this trial is testing

CGM for Insulin-Treated T2DM During Post-Discharge Transition

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Shanghai 6th People's Hospital 160
Not applicableStudy completedNCT02245399
What this trial is testing

Canola-Mediterranean Diet Study in T2DM

Who this might be right for
Type 2 DiabetesObesityOverweight+1 more
Unity Health Toronto 164
Large-scale testing (Phase 3)Study completedNCT02266030
What this trial is testing

Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM

Who this might be right for
Coronary Artery Disease
Seoul National University Bundang Hospital 100
Not applicableNot Yet RecruitingNCT07519265
What this trial is testing

Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Chipscreen Biosciences, Ltd. 64
Not applicableLooking for participantsNCT07167004
What this trial is testing

The GRoceries Aimed at Increasing Nutrition Study

Who this might be right for
Type 2 DiabetesType II Diabetes MellitusType II Diabetes+6 more
University of Pennsylvania 216
Testing effectiveness (Phase 2)Study completedNCT02057172
What this trial is testing

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 254
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Large-scale testing (Phase 3)Looking for participantsNCT06716216
What this trial is testing

BGM0504 in Participants with Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd. 537
Not applicableLooking for participantsNCT05776563
What this trial is testing

Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Yale University 24
Not applicableLooking for participantsNCT07163975
What this trial is testing

Complete Pulpotomy and Root Canal Treatment Patients With Irreversible Pulpitis With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Irreversible Pulpitis
Postgraduate Institute of Dental Sciences Rohtak 106
Post-approval studies (Phase 4)Ended earlyNCT00283049
What this trial is testing

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 390
Testing effectiveness (Phase 2)Study completedNCT02737891
What this trial is testing

Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Saniona 60
Large-scale testing (Phase 3)Study completedNCT05680155
What this trial is testing

Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Who this might be right for
T2DMType 2 Diabetes Mellitus
Hangzhou Sciwind Biosciences Co., Ltd. 211
Not applicableNot Yet RecruitingNCT07412015
What this trial is testing

Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Chipscreen Biosciences, Ltd. 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT07139535
What this trial is testing

RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Who this might be right for
T2DM
Guangdong Raynovent Biotech Co., Ltd 350
Not applicableNot Yet RecruitingNCT07228208
What this trial is testing

Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes (T2DM)Endothelial Dysfunction
Medical College of Wisconsin 40
Very early researchStudy completedNCT05093517
What this trial is testing

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

Who this might be right for
Type 2 DiabetesGlucose Tolerance ImpairedInsulin Sensitivity
The University of Texas Health Science Center at San Antonio 4
Not applicableStudy completedNCT01151293
What this trial is testing

Personality of Diabetic Patients Will Influence Their Medical compliance-a 5 Years Cohort Follow up With Type D Personality

Who this might be right for
Type 2 Diabetes Mellitus
Far Eastern Memorial Hospital
Not applicableStudy completedNCT01529216
What this trial is testing

Efficacy Study of the DIAMOND System to Treat Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
MetaCure Limited 2
Testing effectiveness (Phase 2)Study completedNCT04466904
What this trial is testing

Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM

Who this might be right for
Type 2 Diabetes
Innovent Biologics (Suzhou) Co. Ltd. 42
Load More Results